Pharmaceutical

Kyowa Kirin acquires Orchard Therapeutics for $477.6m

Kyowa Kirin has acquired Orchard Therapeutics, a developer of hematopoietic stem cell gene therapies, for an equity value of $477.6m.

Jan 25, 2024 - 18:00
Kyowa Kirin acquires Orchard Therapeutics for $477.6m
Kyowa Kirin has acquired Orchard Therapeutics, a developer of hematopoietic stem cell gene therapies, for an equity value of $477.6m.
Read the original article

Tags:

Previous Article

Evaxion Biotech to develop new vaccines for cancer

Next Article

Synnovation launches with $102m to advance therapy pipeline

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Why the aspartame in Diet Coke and Coke Zero probably isn’t worth worrying about

Opinion: Why the aspartame in Diet Coke and Coke Zero p...

Jul 8, 2023

These proteins could predict dementia risk decades before symptoms, new study suggests

These proteins could predict dementia risk decades befo...

Jul 20, 2023

Green granulation: Tracking energy efficiency in pharmaceutical granulation

Green granulation: Tracking energy efficiency in pharma...

Mar 1, 2024